Mobile

A Phase 2 Study to Investigate the Safety, Tolerability and Efficacy of ABT-122 in Subjects with Active Psoriatic Arthritis Who Have an Inadequate Response to Methotrexate

Mise à jour : Il y a 4 ans
Référence : EUCTR2014-003558-15

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

The primary objectives are to compare the efficacy of ABT-122 versus placebo in subjects on background methotrexate (MTX) as assessed by ACR20 at Week 12 and to assess the safety and tolerability of ABT-122 in subjects with the active psoriatic arthritis (PsA).

Critère d'inclusion

  • Psoriatic Arthritis

Liens